Jan Alexander

Jan Alexander

Auto-generated profile, based on publicly available information

Jan Alexander

Australian and New Zealand Intensive Care Society Melbourne Australia

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
LSLahn Straney
Lahn Straney
ACArchie Clements
Archie Clements
RPRoger C. Parslow
Roger C. Parslow
GPGale Pearson
Gale Pearson
FSFrank Shann
Frank Shann
ASAnthony Slater
Anthony Slater
To provide an updated version of the Paediatric Index of Mortality 2 for assessing the risk of mortality among children admitted to an ICU. International, multicenter, prospective cohort study. Sixty ICUs that accept pediatric admissions in Australia, New Zealand, Ireland, and the United Kingdom. All children admitted in 2010 and 2011 younger than 18 years old at the time of admission and either died in ICU or were discharged. Patients who were transferred to another ICU were not included. Fifty-three thousand one hundred twelve patient admissions were included in the analysis. None. A revised prediction model was built using logistic regression. Variable selection was based on significance at the 95% level and overall improvement of the model's discriminatory performance and goodness of fit. The final model discriminated well (area under the curve, 0.88, 0.88-0.89); however, the model performed better in Australia and New Zealand than in the United Kingdom and Ireland (area under the curve was 0.91, 0.90-0.93 and 0.85, 0.84-0.86, respectively). Paediatric Index of Mortality 3 provides an international standard based on a large contemporary dataset for the comparison of risk-adjusted mortality among children admitted to intensive care.

1 January 2015 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
LSLuregn J Schlapbach
Luregn J Schlapbach
LSLahn Straney
Lahn Straney
JAJanet Alexander
Janet Alexander
GMGraeme MacLaren
Graeme MacLaren
MFMarino Festa
Marino Festa
ASAnthony Slater
Anthony Slater

1 March 1985 in British Journal of Cancer
Verified
Journal Article
Open access
AGA Green
A Green
VSV Siskind
V Siskind
CBC Bain
C Bain
JAJ Alexander
J Alexander
We investigated the relationship between cutaneous malignant melanoma and multiple sunburns in the Queensland population. Interview data were gathered from 236 case-control pairs concerning their lifetime experience of severe sunburns, their occupational and recreational sun exposure, and their skin type. Excluding the lentigo maligna melanoma subtype, an association between multiple sunburns and melanoma was evident. After controlling for other major risk factors there was a significant dose-response relationship (P less than 0.05): the estimated relative risk associated with 2-5 sunburns in life was 1.5, and with 6 or more was 2.4. This observation extends the hitherto circumstantial evidence of a causal relationship between exposure to solar ultraviolet radiation and melanoma, and suggests that precautionary measures could prevent the development of this disease in a proportion of cases in fair-skinned populations.

27 April 2007 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
TGthe ADVANCE Collaborative Group
the ADVANCE Collaborative Group
PGPaul Glasziou
Paul Glasziou
JAJan Alexander
Jan Alexander
EBElaine Beller
Elaine Beller
PCPhilip Clarke
Philip Clarke
Diabetes has a high burden of illness both in life years lost and in disability through related co-morbidities. Accurate assessment of the non-mortality burden requires appropriate health-related quality of life and summary utility measures of which there are several contenders. The study aimed to measure the impact of diabetes on various health-related quality of life domains, and compare several summary utility measures.

1 May 1993 in Annals of Epidemiology
Verified
Journal Article
Closed access
CBChristopher Bain
Christopher Bain
AGAdèle Green
Adèle Green
VSVictor Siskind
Victor Siskind
JAJan Alexander
Jan Alexander
PHPhilip Harvey
Philip Harvey

1 September 2015 in Critical Care Medicine
Verified
Journal Article
Closed access
SNSiva P. Namachivayam
Siva P. Namachivayam
JAJanet Alexander
Janet Alexander
ASAnthony Slater
Anthony Slater
JMJohnny Millar
Johnny Millar
SESimon Erickson
Simon Erickson
WBWarwick Butt
Warwick Butt
Outcomes for children with chronic critical illness are not defined. We examined the long-term survival of these children in Australia and New Zealand. All cases of PICU chronic critical illness with length of stay more than 28 days and age 16 years old or younger in Australia and New Zealand from 2000 to 2011 were studied. Five-year survival was analyzed using Kaplan-Meir estimates, and risk factors for mortality evaluated using Cox regression. All PICUs in Australia and New Zealand. Nine hundred twenty-four children with chronic critical illness. None. Nine hundred twenty-four children were admitted to PICU for longer than 28 days on 1,056 occasions, accounting for 1.3% of total admissions and 23.5% of bed days. Survival was known for 883 of 924 patients (95.5%), with a median follow-up of 3.4 years. The proportion with primary cardiac diagnosis increased from 27% in 2000-2001 to 41% in 2010-2011. Survival was 81.4% (95% CI, 78.6-83.9) to PICU discharge, 70% (95% CI, 66.7-72.8) at 1 year, and 65.5% (95% CI, 62.1-68.6) at 5 years. Five-year survival was 64% (95% CI, 58.7-68.6) for children admitted in 2000-2005 and 66% (95% CI, 61.7-70) if admitted in 2006-2011 (log-rank test, p = 0.37). After adjusting for admission severity of illness using the Paediatric Index of Mortality 2 score, predictors for 5-year mortality included bone marrow transplant (hazard ratio, 3.66; 95% CI, 2.26-5.92) and single-ventricle physiology (hazard ratio, 1.98; 95% CI, 1.37-2.87). Five-year survival for single-ventricle physiology was 47.2% (95% CI, 34.3-59.1) and for bone marrow transplantation 22.8% (95% CI, 8.7-40.8). Two thirds of children with chronic critical illness survive for at-least 5 years, but there was no improvement between 2000 and 2011. Cardiac disease constitutes an increasing proportion of pediatric chronic critical illness. Bone marrow transplant recipients and single-ventricle physiology have the poorest outcomes.